Camber Pharmaceuticals had more generic approvals in 2021 & 2022 than any other pharmaceutical company in the US. The company successfully launched a record-setting 16 new generic products in the first quarter 2023, include four day-1 launches.
Camber Pharmaceuticals had more generic approvals in 2021 & 2022 than any other pharmaceutical company in the US. The company successfully launched a record-setting 16 new generic products in the first quarter 2023, include four day-1 launches.
